BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7673734)

  • 1. Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease.
    Radic MZ; Ibrahim SM; Rauch J; Camper SA; Weigert M
    J Immunol; 1995 Sep; 155(6):3213-22. PubMed ID: 7673734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light chain contribution to specificity in anti-DNA antibodies.
    Ibrahim SM; Weigert M; Basu C; Erikson J; Radic MZ
    J Immunol; 1995 Sep; 155(6):3223-33. PubMed ID: 7673735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice.
    Roark JH; Kuntz CL; Nguyen KA; Mandik L; Cattermole M; Erikson J
    J Immunol; 1995 May; 154(9):4444-55. PubMed ID: 7722301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of allelic exclusion permits autoreactive B cells to escape deletion.
    Iliev A; Spatz L; Ray S; Diamond B
    J Immunol; 1994 Oct; 153(8):3551-6. PubMed ID: 7930577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ig H and L chain contributions to autoimmune specificities.
    Radic MZ; Mascelli MA; Erikson J; Shan H; Weigert M
    J Immunol; 1991 Jan; 146(1):176-82. PubMed ID: 1898596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of anti-single-stranded DNA B cells in a non-autoimmune background.
    Nguyen KA; Mandik L; Bui A; Kavaler J; Norvell A; Monroe JG; Roark JH; Erikson J
    J Immunol; 1997 Sep; 159(6):2633-44. PubMed ID: 9300682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice.
    Tsao BP; Ohnishi K; Cheroutre H; Mitchell B; Teitell M; Mixter P; Kronenberg M; Hahn BH
    J Immunol; 1992 Jul; 149(1):350-8. PubMed ID: 1607661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
    Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
    J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern.
    Li Y; Li H; Ni D; Weigert M
    J Exp Med; 2002 Dec; 196(12):1543-52. PubMed ID: 12486097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
    Bloom DD; Davignon JL; Cohen PL; Eisenberg RA; Clarke SH
    J Immunol; 1993 Feb; 150(4):1579-90. PubMed ID: 8432994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to DNA in (NZB x NZW)F1 mice that inherit an anti-DNA V(H) as a conventional micro H chain transgene but not as a V(H) knock-in transgene.
    Steeves MA; Marion TN
    J Immunol; 2004 Jun; 172(11):6568-77. PubMed ID: 15153471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
    Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
    Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
    Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
    J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal anti-DNA antibodies: structure, specificity, and biology.
    Marion TN; Krishnan MR; Desai DD; Jou NT; Tillman DM
    Methods; 1997 Jan; 11(1):3-11. PubMed ID: 8990083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse.
    Foster MH; Sabbaga J; Line SR; Thompson KS; Barrett KJ; Madaio MP
    J Immunol; 1993 Jul; 151(2):814-24. PubMed ID: 8335911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells.
    Fukuyama H; Nimmerjahn F; Ravetch JV
    Nat Immunol; 2005 Jan; 6(1):99-106. PubMed ID: 15592473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
    Makdasi E; Fischel R; Kat I; Eilat D
    J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
    Li J; Geissal ED; Li W; Stollar BD
    Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.